ID Analysts

Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.

Analyst Articles

Last week when the market was looking shaky we closed out the bullish side of our long straddle, selling the iShares Russell 2000 (IWM) April 114 call option at essentially break even. Stocks continued to slide, which propelled our April 114 iShares Russell 2000 (IWM) put option higher. Yesterday, with… Read More

Sell to close the iShares Russell 2000 (IWM) April 114 put option, at the market. After several days of the declines, the stock market's correction appears close to have run its course, at least for now. That’s the message of our proprietary market indicators which, while still slightly negative,… Read More

U.S. stocks are on track for their worst one-week performance of the year. Some mixed earnings results from heavyweights such as IBM, Intel, Citigroup, and others plus soft manufacturing readings both at home and from abroad gave investors reasons to reassess the economic outlook and current stock valuations after equities… Read More

Sell to close the iShares Russell 2000 (IWM) April 114 call option, at the market. Stocks are looking more vulnerable after yesterday’s selloff and weakness today following Argentina devaluing its peso and currencies of other emerging economies weakening. We therefore no longer want to hold a hedged position and… Read More

Stocks in the U.S. are struggling to gain traction. This is not to say that the market picture has deteriorated – but the indices clearly need some kind of a trigger to move to the next level. This earnings season, so far, isn’t it. On the other hand, economic data… Read More

The improved growth indications are being reflected in base metals prices and in the upward move in the PowerShares DB Base Metals ETF (DBB) during the past week. The ETF is a good way to play faster economic growth worldwide, and it remains a buy on margin at current levels. Read More

The week began with the worst one-day performance for the S&P 500 in more than two months as investors blinked after the President of the Federal Reserve Bank of Atlanta Dennis Lockhart (a non-voting Fed member this year) remarked that he supported "similar tapering steps" (namely, the $10 billion per… Read More

We are reducing our Idenix Pharmaceuticals (IDIX) position by one quarter. IDIX will now be approximately 6.5 percent to 7 percent of our portfolio. Since we purchased more Idenix Pharmaceuticals (IDIX) shares in mid-December, the stock has rallied about 50 percent. It's having another huge day today. Read More

Stocks suffered their biggest one-day drop in two months yesterday with no single catalyst that could be pointed to for the blame. Concerns about fourth-quarter earnings are an obvious candidate, with the reporting season just getting under way now. Modest corrections of 5 percent and even 7 percent, however, really… Read More

Last week, believing that market volatility was poised to rise but not entirely convinced stocks would fall immediately, we established a long straddle using options on the Russell 2000 ETF. New clients can still purchase the iShares Russell 2000 (IWM) April 114 call option and an equal number of the… Read More